Literature DB >> 7957605

Effect of ivermectin on gamma-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones.

J Krůsek1, H Zemková.   

Abstract

The effect of ivermectin on gamma-aminobutyric acid (GABA)-induced Cl- currents was studied in embryonicse hippocampal cells in culture. When 0.1 microM ivermectin was applied to the perfusion medium, the responses to 2 microM GABA were enhanced to 273% within 60 s, and the GABA EC50 was reduced from 8.2 to 3.2 microM. Half-maximal potentiation of GABA responses was found with 17.8 nM ivermectin. The potentiating effect of ivermectin diminished to 146% within 10 min but the GABA EC50 did not change any further. At the same time, the maximal GABA-induced Cl- current decreased to 64%. Both the fast and slow desensitization time constants of GABA-activated membrane currents were shortened after ivermectin application. The final effect of ivermectin was irreversible. Modulation of the GABA responses by ivermectin did not interfere with the potentiation induced by diazepam and pentobarbital or with the sensitivity to blockade by bicuculline, picrotoxin and Zn2+. These results support the view that ivermectin binds to a novel site on the GABAA receptor and allosterically enhances the affinity of the GABA binding site. The more slowly occurring conformational changes in the ivermectin-GABAA receptor complex apparently accelerate the desensitization of the GABAA receptor, reducing the amplitude of maximal GABA-induced currents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957605     DOI: 10.1016/0014-2999(94)90500-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  31 in total

1.  Allosteric control of gating and kinetics at P2X(4) receptor channels.

Authors:  B S Khakh; W R Proctor; T V Dunwiddie; C Labarca; H A Lester
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

Review 2.  Allosteric modulation of ATP-gated P2X receptor channels.

Authors:  Claudio Coddou; Stanko S Stojilkovic; J Pablo Huidobro-Toro
Journal:  Rev Neurosci       Date:  2011-03-16       Impact factor: 4.353

3.  Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin.

Authors:  N S Kane; B Hirschberg; S Qian; D Hunt; B Thomas; R Brochu; S W Ludmerer; Y Zheng; M Smith; J P Arena; C J Cohen; D Schmatz; J Warmke; D F Cully
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator.

Authors:  Toby Collins; Neil S Millar
Journal:  Mol Pharmacol       Date:  2010-05-12       Impact factor: 4.436

5.  Altered hippocampal synaptic potentiation in P2X4 knock-out mice.

Authors:  Joan A Sim; Séverine Chaumont; Jihoon Jo; Lauriane Ulmann; Mark T Young; Kwangwook Cho; Gary Buell; R Alan North; Francois Rassendren
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

Review 6.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

Review 7.  Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.

Authors:  Jingyi Wang; Jon Lindstrom
Journal:  Br J Pharmacol       Date:  2017-03-20       Impact factor: 8.739

8.  Characterization of purinergic P2X4 receptor channels expressed in anterior pituitary cells.

Authors:  Hana Zemkova; Marek Kucka; Shuo Li; Arturo E Gonzalez-Iglesias; Melanija Tomic; Stanko S Stojilkovic
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

Review 9.  Allosteric modulation of glycine receptors.

Authors:  Gonzalo E Yevenes; Hanns Ulrich Zeilhofer
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 10.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.